Several years ago a new lung cancer drug was being evaluated, and when the authors looked at whose tumors shrank, they found that 82 percent were women.
Hace varios años se estudiaba un nuevo medicamento para el cáncer pulmonar, y cuando los autores estudiaron cuáles tumores se redujeron encontraron que el 82% eran mujeres.